Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
about
Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its managementFeasibility and limitations of bulk density assignment in MRI for head and neck IMRT treatment planning.Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapyClinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer.Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinomaAnalysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas.Radiobiological evaluation of forward and inverse IMRT using different fractionations for head and neck tumours.Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapyPromising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy.New conformity indices based on the calculation of distances between the target volume and the volume of reference isodose.The use of biologically related model (Eclipse) for the intensity-modulated radiation therapy planning of nasopharyngeal carcinomas.Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience.Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma.The combined effect of individual and neighborhood socioeconomic status on nasopharyngeal cancer survivalWhich T category of nasopharyngeal carcinoma may benefit most from volumetric modulated arc therapy compared with step and shoot intensity modulated radiation therapy.Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies.Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.A dosimetric comparison of two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer.Implementation of IMRT in the radiotherapy department.Incidence of and Risk Factors for Mastoiditis after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma.Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.Prognostic value of the distance between the primary tumor and brainstem in the patients with locally advanced nasopharyngeal carcinomaDosimetric benefits of placing dose constraints on the brachial plexus in patients with nasopharyngeal carcinoma receiving intensity-modulated radiation therapy: a comparative study.Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.Current and emerging treatment options for nasopharyngeal carcinoma.Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.Dosimetry Comparison between Volumetric Modulated Arc Therapy with Rapid Arcand Fixed Field Dynamic IMRT for Local-Regionally Advanced Nasopharyngeal Carcinoma.Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysisNew developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.Radiation-induced temporal lobe injury for nasopharyngeal carcinoma: a comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapy.High-risk factors of parotid lymph node metastasis in nasopharyngeal carcinoma: a case-control study.Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients.Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue.Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma.
P2860
Q24634976-0B117C97-606E-45C5-8307-9638D0786A5DQ30849754-86B72033-7BE3-4880-B5AF-2D2734A264FCQ33683013-F8EDA28C-DC99-4706-8DE5-487BC3DACC90Q33689119-CE8AE16B-09A1-492D-BEBD-22ED40B0D931Q33726601-A5F6B858-4EB4-4D20-AEA3-C4C61D56869AQ33889375-E26727F0-BF04-4132-AC87-E6E7B38EF026Q33907143-3448A0A4-571A-415F-8632-C5A419DCD478Q34008879-0286092D-C5D8-464B-A065-B25F39A9E856Q34069855-49EA0055-74CA-4C09-9D6F-EFA7CF807728Q34159567-AD902F63-30AF-4587-AABA-CF74208098C5Q34185676-F502EEA0-AAF8-453E-8EE6-AEAAAD8DD87CQ34250979-35D2ACA0-9EC5-44E1-8842-CA3A68661D79Q34392141-A041AEC2-BE3B-427E-8166-830471F76FA3Q34459534-0C1F1285-7F33-426B-AAFB-A42C99C3DCF7Q34477214-F141A951-00E4-4C0F-9BD7-74CB793E48A5Q34788288-601E0482-2EB6-4929-842B-C60405DD72F0Q34998889-C330E5BA-F259-497B-8107-14EF0BAF09DFQ35005542-21C38BE9-03D3-4FBF-881E-11BF296453C6Q35046426-2EFC0E09-ECB8-48C7-AF5A-34B3557E3F96Q35114677-9BDD04B4-D157-48AD-BCE4-947DD27759DFQ35591783-67AD2D35-1D95-4B59-ACCB-FE2CC6F502BDQ35623587-A559EFF4-E24C-4D52-9384-F1F63371919DQ35675444-249DBE63-1AEF-4E12-895C-B827024402E0Q35908143-037F4A45-8878-401F-9977-CC61206E29E7Q35925599-79EDD5EE-F63C-4213-8100-D3A6AC1733F9Q36066990-D5A03BBE-097E-4FDD-B4E5-05CA6A27C74BQ36100299-73496091-E22D-4BFC-AFF4-E359001162F4Q36247439-771799EF-B9B4-4ED2-824D-AD150EB3A419Q36359374-2F579801-39DF-4BED-B53E-F81ED9AF7993Q36546073-8EFE45F8-9F06-4346-8613-5907AFAE06B1Q36551114-87B7FDC7-ABB5-4023-9AD8-368FC3D887F8Q36690259-B9318131-2FFE-4A04-A5F1-2709935C75B4Q36807138-EAE12109-826A-4AA4-B34E-340B092DC6E3Q37001059-67D7397D-B486-46E0-9A2E-74ABDD938419Q37228349-02E07949-4DF1-4FFB-A97B-10982B006A84Q37287053-5B775828-14F5-4FAC-8885-CBC080BE8F5BQ37348334-88F06C1A-8D74-41C8-BEAA-14973242F280Q37355792-82D73AEF-4C0C-41E2-898F-7B02A763F0FCQ37418009-033D10A5-CEBC-4C18-9AF2-D4CDB7EF029DQ37450565-86A93A7E-6F36-4D87-8F18-5925C477514A
P2860
Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Intensity-modulated radiothera ...... easibility of dose escalation.
@en
Intensity-modulated radiothera ...... easibility of dose escalation.
@nl
type
label
Intensity-modulated radiothera ...... easibility of dose escalation.
@en
Intensity-modulated radiothera ...... easibility of dose escalation.
@nl
prefLabel
Intensity-modulated radiothera ...... easibility of dose escalation.
@en
Intensity-modulated radiothera ...... easibility of dose escalation.
@nl
P2093
P1476
Intensity-modulated radiothera ...... easibility of dose escalation.
@en
P2093
Joyce Suen
Michael K M Kam
Peter H K Choi
Peter M L Teo
Ricky M C Chau
P304
P356
10.1016/S0360-3016(03)00075-0
P407
P577
2003-05-01T00:00:00Z